PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24704452-0 2014 22(R)-hydroxycholesterol and pioglitazone synergistically decrease cholesterol ester via the PPARgamma-LXRalpha-ABCA1 pathway in cholesterosis of the gallbladder. Pioglitazone 29-41 ATP binding cassette subfamily A member 1 Homo sapiens 112-117 25280398-0 2015 Pioglitazone reduces lipid droplets in cholesterolosis of the gallbladder by increasing ABCA1 and NCEH1 expression. Pioglitazone 0-12 ATP binding cassette subfamily A member 1 Homo sapiens 88-93 25280398-9 2015 In conclusion, we observed that pioglitazone increased ABCA1 expression in an LXR-dependent manner and NCEH1 expression in an LXRalpha-independent manner, which mobilized CE hydrolysis and cholesterol efflux to reduce lipid droplet content in cholesterolosis GBECs. Pioglitazone 32-44 ATP binding cassette subfamily A member 1 Homo sapiens 55-60 11712406-8 2001 Recently, it was demonstrated that pioglitazone is also an agonist of PPAR-alpha, which plays a central role in lipid metabolism through enhancing the synthesis of apo AI, apo AII and reverse cholesterol transporters, such as fatty acid transporter molecules, and SR-B1 and ABCA1 reverse cholesterol transport receptors. Pioglitazone 35-47 ATP binding cassette subfamily A member 1 Homo sapiens 274-279 24704452-10 2014 The combination of 22(R)-hydroxycholesterol and pioglitazone resulted in a 3.64-fold increase in ABCA1 expression and a high rate of cholesterol efflux. Pioglitazone 48-60 ATP binding cassette subfamily A member 1 Homo sapiens 97-102 24704452-12 2014 In conclusion, the present findings indicate that the anti-lipid deposition action of 22(R)-hydroxycholesterol combined with pioglitazone involves the activation of the PPARgamma-LXRalpha-ABCA1 pathway, increased ABCA1 expression and the efflux of cholesterol from GBECs. Pioglitazone 125-137 ATP binding cassette subfamily A member 1 Homo sapiens 188-193 24704452-12 2014 In conclusion, the present findings indicate that the anti-lipid deposition action of 22(R)-hydroxycholesterol combined with pioglitazone involves the activation of the PPARgamma-LXRalpha-ABCA1 pathway, increased ABCA1 expression and the efflux of cholesterol from GBECs. Pioglitazone 125-137 ATP binding cassette subfamily A member 1 Homo sapiens 213-218 21862012-0 2011 Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARgamma/LXRalpha pathway: findings from in vitro and ex vivo studies. Pioglitazone 0-12 ATP binding cassette subfamily A member 1 Homo sapiens 72-77 21862012-4 2011 We therefore investigated the effects of pioglitazone on ABCA1/G1 expression in vitro and ex vivo. Pioglitazone 41-53 ATP binding cassette subfamily A member 1 Homo sapiens 57-62 21862012-9 2011 RESULTS: Pioglitazone increased LXRalpha/ABCA1/G1 expressions, which enhanced ChE from macrophages. Pioglitazone 9-21 ATP binding cassette subfamily A member 1 Homo sapiens 41-46 21862012-10 2011 Inhibition of PPARgamma/LXR pathways revealed that LXR was primarily involved in pioglitazone"s transactivation of ABCA1 but only partially involved for ABCG1. Pioglitazone 81-93 ATP binding cassette subfamily A member 1 Homo sapiens 115-120 21862012-12 2011 Sera obtained after pioglitazone treatment promoted ChE and ABCA1/G1 expressions in macrophages. Pioglitazone 20-32 ATP binding cassette subfamily A member 1 Homo sapiens 60-65 21862012-13 2011 CONCLUSION: Pioglitazone enhanced ChE from macrophages by increasing ABCA1/G1 in LXR-dependent and -independent manners. Pioglitazone 12-24 ATP binding cassette subfamily A member 1 Homo sapiens 69-74 20110608-4 2010 We observed that pioglitazone, but not GW347845, increased cholesterol biosynthetic and lipogenic gene expression after 6 h, and the expression of the cholesterol efflux transporters Abca1 and Abcg1 after 24 h. Co-treatment of pioglitazone with the PPARgamma antagonist GW9662 did not significantly reduce these effects, suggesting a PPARgamma-independent mechanism. Pioglitazone 17-29 ATP binding cassette subfamily A member 1 Homo sapiens 183-188